Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Current Assets (2021 - 2025)

Historic Current Assets for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $360.4 million.

  • LifeStance Health's Current Assets rose 2555.81% to $360.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $360.4 million, marking a year-over-year increase of 2555.81%. This contributed to the annual value of $312.5 million for FY2024, which is 3844.35% up from last year.
  • Latest data reveals that LifeStance Health reported Current Assets of $360.4 million as of Q3 2025, which was up 2555.81% from $358.8 million recorded in Q2 2025.
  • LifeStance Health's Current Assets' 5-year high stood at $364.1 million during Q2 2021, with a 5-year trough of $212.5 million in Q1 2023.
  • Its 5-year average for Current Assets is $279.9 million, with a median of $265.4 million in 2021.
  • Its Current Assets has fluctuated over the past 5 years, first plummeted by 3289.95% in 2022, then soared by 3844.35% in 2024.
  • LifeStance Health's Current Assets (Quarter) stood at $266.5 million in 2021, then decreased by 12.49% to $233.2 million in 2022, then fell by 3.21% to $225.7 million in 2023, then surged by 38.44% to $312.5 million in 2024, then rose by 15.32% to $360.4 million in 2025.
  • Its last three reported values are $360.4 million in Q3 2025, $358.8 million for Q2 2025, and $304.6 million during Q1 2025.